When will the U.S. develop concise generic biologic rules?
22. Sep, 2008 
1 Comment
A lot of people have been asking my opinion on when a concise generic biologic regulatory pathway will emerge in the United States, and I give them all the same answer: Later.
In my opinion complex regulatory schemes are not areas in which the United States can effectively lead. Why not? Because the size of the [...]
